The United States remains a key contributor to the Alfentanil Market, supported by a well-established healthcare infrastructure, a high volume of surgical procedures, and increasing demand for advanced anesthesia solutions. The growing prevalence of chronic diseases, coupled with rising outpatient surgeries and expanding ambulatory surgical centers, continues to drive the adoption of alfentanil...